News

FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
The New Republic12dOpinion
An Anti-Science MAHA Extremist Is Playing a Major Role at the FDA
On first glance, Dr. Vinay Prasad’s medical credentials sound impressive. But look closer and you’ll find a narcissistic ...
Vaccines Face Uncertain Approval, Reviews With New FDA Official
The appointment of a vocal critic of expedited approvals of vaccines, Vinay Prasad, to run the FDA’s office responsible for ...
Endpoints News9d
In his first ma­jor pol­i­cy roll­out, Vinay Prasad looks to chal­lenge ex­ist­ing 'dog­ma' on Covid vac­cines
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...
India West3d
FDA Taps Vaxxer Skeptic Vinay Prasad To Oversee Vaccine, Gene Therapy Regulations
The appointment, announced May 6 by FDA Commissioner Dr. Marty Makary, places Prasad at the helm of one ... is precisely what the agency needs. “Vinay is willing to ask tough questions about ...
Lisa Jarvis: FDA appointee is a drug critic with a lot to prove
The gravity of these decisions calls for a degree of humility on the part of an FDA leader. And that’s the rub with Vinay ...
Clinical Trials Arena on MSN8d
Navigating the FDA’s accelerated approval pathways for oncology drugs
At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...
COVID Vaccine Makers Catch a Break in FDA Policy Shift
Moderna is counting on revenue from newer mRNA vaccines, including a next generation Covid shot, to make up for falling sales ...
Who can get updated COVID vaccines this fall? FDA tightening rules
The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...
Infectious Disease Advisor2d
FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access
The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.
The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
The Pharma Letter9d
FDA officials unwisely limit COVID-19 vaccine, says Public Citizen
The US Food and Drug Administration (FDA) is set to sharply restrict vaccine availability to millions of Americans without a ...